Cyclophosphamide for Refractory Acute Cellular Rejection After Lung Transplantation
Background. Acute cellular rejection (ACR) is a major risk factor for chronic lung allograft dysfunction after lung transplantation. Acute cellular rejection can persist or recur despite augmentation of immunosuppression by conventional methods. There are limited therapeutic options in treating thes...
-д хадгалсан:
| Үндсэн зохиолчид: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
Wolters Kluwer
2018-05-01
|
| Цуврал: | Transplantation Direct |
| Онлайн хандалт: | http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000000790 |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|